KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Assets Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.51%
Dec 31, 2025 -1.36%
Sep 30, 2025 -0.82%
Jun 30, 2025 -3.31%
Mar 31, 2025 -3.89%
Dec 31, 2024 -5.47%
Sep 30, 2024 0.39%
Jun 30, 2024 0.71%
Mar 31, 2024 4.80%
Dec 31, 2023 49.19%
Sep 30, 2023 42.13%
Jun 30, 2023 52.24%
Mar 31, 2023 49.87%
Dec 31, 2022 6.47%
Sep 30, 2022 -1.99%
Jun 30, 2022 -0.80%
Mar 31, 2022 -5.35%
Dec 31, 2021 -2.83%
Sep 30, 2021 0.55%
Jun 30, 2021 -8.06%
Mar 31, 2021 1.41%
Dec 31, 2020 5.43%
Sep 30, 2020 8.57%
Jun 30, 2020 9.50%
Mar 31, 2020 -3.64%
Dec 31, 2019 -10.10%
Sep 30, 2019 -11.58%
Jun 30, 2019 -12.28%
Mar 31, 2019 -10.07%
Dec 31, 2018 -16.93%
Sep 30, 2018 -16.18%
Jun 30, 2018 -14.96%
Mar 31, 2018 -8.60%
Dec 31, 2017 3.00%
Sep 30, 2017 2.79%
Jun 30, 2017 5.45%
Mar 31, 2017 3.66%
Dec 31, 2016 8.65%
Sep 30, 2016 8.74%
Jun 30, 2016 5.99%
Mar 31, 2016 8.94%
Dec 31, 2015 3.54%
Sep 30, 2015 1.55%
Jun 30, 2015 2.41%
Mar 31, 2015 2.91%
Dec 31, 2014 4.36%
Sep 30, 2014 24.01%
Jun 30, 2014 32.17%
Mar 31, 2014 29.75%
Dec 31, 2013 21.78%
Sep 30, 2013 2.93%
Dec 31, 2012 11.10%